Caina Technology Co

Caina Technology Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 1,215.36. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 45.28 — a change of 2,584.15% (higher).

EV/EBITDA

1,215.36

YoY

2,584.15%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Caina Technology Co is 2025 1,215.36 . EV/EBITDA (Enterprise Value to EBITDA) of Caina Technology Co was 2024 45.28 . It decreases by 2,584.15% higher compared to the previous year.

The Caina Technology Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
161.19 CNY
Jan 1, 2019
89.66 CNY
Jan 1, 2020
22.68 CNY
Jan 1, 2021
23.83 CNY
Jan 1, 2022
14.43 CNY
Jan 1, 2023
21.34 CNY
Jan 1, 2024
45.28 CNY
Jan 1, 2025
1,215.36 CNY
The Caina Technology Co EV/EBITDA history
YEAREV/EBITDAYoY
1,215.36+2,584.15%
45.28+112.16%
21.34+47.92%
14.43-39.46%
23.83+5.07%
22.68-74.70%
89.66-44.37%
161.19-48.32%
311.87—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

EV/EBITDA (Enterprise Value to EBITDA) of Caina Technology Co is 1,215.36 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Caina Technology Co changed from 45.28 to 1,215.36, representing a 2,584.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Caina Technology Co

All Key Metrics — Caina Technology Co